Annual Accounts Receivable
$176.60 K
+$176.60 K+100.00%
September 30, 2024
Summary
- As of March 13, 2025, NMTC annual accounts receivable is $176.60 thousand, with the most recent change of +$176.60 thousand (+100.00%) on September 30, 2024.
- During the last 3 years, NMTC annual accounts receivable has risen by +$128.30 thousand (+265.63%).
- NMTC annual accounts receivable is now at all-time high.
Performance
NMTC Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$2.37 M
+$2.19 M+1241.39%
December 31, 2024
Summary
- As of March 13, 2025, NMTC quarterly accounts receivable is $2.37 million, with the most recent change of +$2.19 million (+1241.39%) on December 31, 2024.
- Over the past year, NMTC quarterly accounts receivable has increased by +$1.83 million (+335.94%).
- NMTC quarterly accounts receivable is now at all-time high.
Performance
NMTC Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
NMTC Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | +335.9% |
| 3 y3 years | +265.6% | +335.9% |
| 5 y5 years | - | +335.9% |
NMTC Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | at high | -100.0% |
| 5 y | 5-year | at high | -100.0% | at high | -100.0% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
NeuroOne Medical Technologies Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $2.37 M(+1241.4%) |
| Sep 2024 | $176.60 K(>+9900.0%) | $176.60 K(-57.0%) |
| Jun 2024 | - | $410.60 K(-26.1%) |
| Mar 2024 | - | $555.60 K(+2.2%) |
| Dec 2023 | - | $543.40 K(>+9900.0%) |
| Sep 2023 | $0.00 | $0.00(0.0%) |
| Jun 2023 | - | $0.00(-100.0%) |
| Mar 2023 | - | $214.00 K(+124.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | - | $95.30 K(+187.0%) |
| Sep 2022 | $33.20 K(-31.3%) | $33.20 K(>+9900.0%) |
| Jun 2022 | - | $0.00(-100.0%) |
| Mar 2022 | - | $36.60 K(+48.8%) |
| Dec 2021 | - | $24.60 K(-49.1%) |
| Sep 2021 | $48.30 K(>+9900.0%) | $48.30 K(+20.4%) |
| Jun 2021 | - | $40.10 K(-43.9%) |
| Dec 2020 | - | $71.50 K(>+9900.0%) |
| Sep 2020 | $0.00 | $0.00 |
FAQ
- What is NeuroOne Medical Technologies annual accounts receivable?
- What is the all time high annual accounts receivable for NeuroOne Medical Technologies?
- What is NeuroOne Medical Technologies annual accounts receivable year-on-year change?
- What is NeuroOne Medical Technologies quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for NeuroOne Medical Technologies?
- What is NeuroOne Medical Technologies quarterly accounts receivable year-on-year change?
What is NeuroOne Medical Technologies annual accounts receivable?
The current annual accounts receivable of NMTC is $176.60 K
What is the all time high annual accounts receivable for NeuroOne Medical Technologies?
NeuroOne Medical Technologies all-time high annual accounts receivable is $176.60 K
What is NeuroOne Medical Technologies annual accounts receivable year-on-year change?
Over the past year, NMTC annual accounts receivable has changed by +$176.60 K (+100.00%)
What is NeuroOne Medical Technologies quarterly accounts receivable?
The current quarterly accounts receivable of NMTC is $2.37 M
What is the all time high quarterly accounts receivable for NeuroOne Medical Technologies?
NeuroOne Medical Technologies all-time high quarterly accounts receivable is $2.37 M
What is NeuroOne Medical Technologies quarterly accounts receivable year-on-year change?
Over the past year, NMTC quarterly accounts receivable has changed by +$1.83 M (+335.94%)